Nivolumab in the Treatment of Patients With Non-small Cell Lung Cancer: The Australian Experience
Nivolumab in the Treatment of Patients With Non-small Cell Lung Cancer: The Australian Experience
This study is to capture and describe the patient and disease characteristics and the outcomes of adult patients with previously-treated advanced NSCLC who have been treated with Nivolumab
Inclusion Criteria
Exclusion Criteria:
Other protocol defined inclusion/exclusion criteria could apply
Heidelburg, Victoria 3084, Australia